Share on LinkedInShare on LinkedIn

ARTICLE · 11 MAY 2009

FSA Wider Implications Referral Lehman-Backed Structured Products

FSA has today announced that it is going to review firms' sales of Lehman backed structured products (Lehman backed products) to retail investors.

United KingdomStrategy
Simon Morris
Simon Morris
Alison McHaffie
Alison McHaffie

FSA has today announced that it is going to review firms' sales of Lehman backed structured products (Lehman backed products) to retail investors. This raises important issues for affected investors, for firms that sold Lehman backed products, and for the structured product market as a whole.

Background

In recent years many retail providers have sought to meet investor demand for constant yield or high growth by issuing retail structured products. While varying in design, these typically offer a set income or level of capital growth over a pre-determined period of three to five years. They are generally linked to instruments purchased from an investment bank that deliver the performance that enables the provider to offer the promised benefits. The counterparty risk involved in retail structured products has only recently become a primary commercial or regulatory focus, especially after the collapse of Lehman Brothers in September 2008 resulted in significant losses

We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.

See more popular content from